4//SEC Filing
BFI Co., LLC 4
Accession 0001144204-18-045022
CIK 0001069899other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 9:09 PM ET
Size
12.8 KB
Accession
0001144204-18-045022
Insider Transaction Report
Form 4
BFI Co., LLC
10% Owner
Transactions
- Conversion
Class A Common Stock
2018-08-13+60,000→ 60,000 total - Sale
Class A Common Stock
2018-08-13$50.03/sh−10,000$500,300→ 50,000 total - Sale
Class A Common Stock
2018-08-14$49.90/sh−10,000$499,000→ 40,000 total - Conversion
Class B Common Stock
2018-08-13−60,000→ 20,246,034 totalExercise: $0.00→ Class A Common Stock (60,000 underlying) - Sale
Class A Common Stock
2018-08-15$49.33/sh−10,000$493,300→ 30,000 total
Footnotes (5)
- [F1]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $50.85, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.60 to $50.20, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.75, inclusive.
Documents
Issuer
PHIBRO ANIMAL HEALTH CORP
CIK 0001069899
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001601607
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 9:09 PM ET
- Size
- 12.8 KB